lobbying_activities: 1237782

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1237782	937fcabc-20d9-4259-86b2-f0eda94d4225	Q1	PODESTA GROUP, INC.	31680	EISAI INC.	2012	first_quarter	PHA	Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2012-04-19T14:30:32.033000-04:00